), a leader in non-invasive monitoring technology for patient
care, together with the U.S.-based Saint Alphonsus Regional
Medical Center, recently reported that the latter will purchase
its Masimo Patient SafetyNet. The 387-bed facility will install
the device in patient rooms on orthopedic, general surgery, and
COVIDIEN PLC (COV): Free Stock Analysis
GIVEN IMAGING (GIVN): Get Free Report
LUMINEX CORP (LMNX): Free Stock Analysis
MASIMO CORP (MASI): Free Stock Analysis
To read this article on Zacks.com click here.
Masimo Patient SafetyNet is a remote monitoring and clinician
notification system that combines Masimo SET pulse oximetry with
wireless notification and monitoring of ventilation. It instantly
routes bedside-generated alarms through a server to a clinician's
hand-held paging device in real-time. Each system is capable of
supporting up to 80 bedside monitors and can either be integrated
into a hospital's existing IT infrastructure or operate as a
stand-alone wireless network.
Earlier, Masimo had forged an agreement with University
Children's Hospital in Basel, Switzerland. The hospital was the
first pediatric institution in the region to utilize the Masimo
Patient SafetyNet in its general wards.
According to the U.S. News & World Report Best Hospitals
Honor Roll, MASI's popular Masimo SET is used in 8 out of the top
10 hospitals to monitor more than 100 million patients annually.
Its accurate measurements, along with increased specificity as
well as sensitivity, help to identify fatal breathing
difficulties even during patient motion and low perfusion rate.
Further, the Masimo SET provides excellent support to clinicians
to reduce retinopathy of prematurity (ROP) in neonates, screen
newborns for Critical Congenital Heart Disease (CCHD), as well as
perform other functions to improve patient outcome in a
However, MASI's product line faces stiff competition from
) Nellcor pulse oximeters. The company has started labeling the
device to promote the usefulness of the product line for CCHD
screening in infants. Moreover, the Food and Drug Administration
(FDA) has approved Covidien's Nellcor Bedside SpO2 Patient
Monitoring System, Bedside Respiratory Patient Monitoring System,
and N-600x Pulse Oximetry Monitoring System for motion tolerance.
Masimo has a Zacks Rank #3 (Hold). Other medical instruments
stocks that are worth considering include
). All these stocks carry a Zacks Rank #2 (Buy).